Compare Indo Straits Tbk. (PTIS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indo Straits Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Indo Straits Tbk. trades at Rp270 (market cap 149.64B, 147.4K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 78.1× Indo Straits Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (429.7K versus 147.4K). Which is the better fit depends on your goals.
| PTIS | TSPC | |
|---|---|---|
Market Cap | 149.64B | 11.68T |
Volume | 147.4K | 429.7K |
Lot | 1.47K | 4.3K |
Turnover | 39.56M | 1.11B |
Average Price | 268.4 | 2,591.65 |
Value | 39.56M | 1.11B |
Indicative Equilibrium Price | 270 | 2,580 |
Indicative Equilibrium Volume | 71 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indo Straits Tbk.
PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Read more on PTIS →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
